| Sanara MedTech Inc. SMTI | $9.8M | 11.36 | 980,000 | New | +$9.8M | 0.97 | |
| Tenaya Therapeutics, Inc. TNYA | $11.77M | 2.87 | 2.25M | New | +$11.77M | 1.17 | |
Longboard Pharmaceuticals, Inc. LBPH | $21.06M | 2.51 | 975,000 | +8.33% | +$1.62M | 2.09 | |
| Tarsus Pharmaceuticals, Inc. TARS | $21.45M | 1.56 | 590,000 | +490% | +$17.81M | 2.12 | |
| REGENXBIO Inc. RGNX | $16.01M | 1.54 | 760,000 | +133.85% | +$9.17M | 1.59 | |
| Insmed Incorporated INSM | $35.27M | 0.88 | 1.3M | +271.43% | +$25.77M | 3.49 | |
| Vera Therapeutics, Inc. VERA | $15.52M | 0.66 | 360,000 | New | +$15.52M | 1.54 | |
| 4D Molecular Therapeutics, Inc. FDMT | $7.96M | 0.48 | 250,000 | -33.33% | -$3.98M | 0.79 | |
| Arcellx, Inc. ACLX | $17.74M | 0.48 | 255,000 | +59.38% | +$6.61M | 1.76 | |
| Tenet Healthcare Corporation THC | $44.67M | 0.44 | 425,000 | +21.43% | +$7.88M | 4.43 | |
| Crinetics Pharmaceuticals, Inc. CRNX | $15.21M | 0.41 | 325,000 | +62.5% | +$5.85M | 1.51 | |
| Viking Therapeutics, Inc. VKTX | $36.9M | 0.41 | 450,000 | -10% | -$4.1M | 3.66 | |
| Cytokinetics, Incorporated CYTK | $31.55M | 0.39 | 450,000 | +125% | +$17.53M | 3.13 | |
| Tandem Diabetes Care, Inc. TNDM | $7.97M | 0.35 | 225,000 | New | +$7.97M | 0.79 | |
| Encompass Health Corporation EHC | $28.9M | 0.35 | 350,000 | +40% | +$8.26M | 2.86 | |
| Inari Medical, Inc. NARI | $9.6M | 0.34 | 200,000 | +100% | +$4.8M | 0.95 | |
MoonLake Immunotherapeutics MLTX | $11.05M | 0.34 | 220,000 | 0% | +$0 | 1.1 | |
| Blueprint Medicines Corporation BPMC | $19.92M | 0.34 | 210,000 | +50% | +$6.64M | 1.97 | |
| Krystal Biotech, Inc. KRYS | $14.23M | 0.28 | 80,000 | -5.88% | -$889,650.00 | 1.41 | |
| CRISPR Therapeutics AG CRSP | $15M | 0.26 | 220,000 | New | +$15M | 1.49 | |
| Revolution Medicines, Inc. RVMD | $13.54M | 0.26 | 420,000 | +110% | +$7.09M | 1.34 | |
| Evolent Health, Inc. EVH | $8.2M | 0.22 | 250,000 | 0% | +$0 | 0.81 | |
| Oscar Health, Inc. OSCR | $7.43M | 0.21 | 500,000 | New | +$7.43M | 0.74 | |
| Universal Health Services, Inc. UHS | $22.81M | 0.19 | 125,000 | +78.57% | +$10.04M | 2.26 | |
| Penumbra, Inc. PEN | $15.62M | 0.18 | 70,000 | +75% | +$6.7M | 1.55 | |
| Walgreens Boots Alliance, Inc. WBA | $28.2M | 0.15 | 1.3M | +18.18% | +$4.34M | 2.79 | |
| Bruker Corporation BRKR | $20.67M | 0.15 | 220,000 | +120% | +$11.27M | 2.05 | |
| Neurocrine Biosciences, Inc. NBIX | $20.69M | 0.15 | 150,000 | +66.67% | +$8.28M | 2.05 | |
| Charles River Laboratories International, Inc. CRL | $17.61M | 0.13 | 65,000 | 0% | +$0 | 1.74 | |
| Apellis Pharmaceuticals, Inc. APLS | $8.82M | 0.12 | 150,000 | New | +$8.82M | 0.87 | |
| Intra-Cellular Therapies, Inc. ITCI | $8.65M | 0.12 | 125,000 | -28.57% | -$3.46M | 0.86 | |
| Elanco Animal Health Incorporated ELAN | $8.95M | 0.11 | 550,000 | +10% | +$814,000.00 | 0.89 | |
ShockWave Medical, Inc. SWAV | $13.03M | 0.11 | 40,000 | New | +$13.03M | 1.29 | |
| Repligen Corporation RGEN | $9.2M | 0.09 | 50,000 | -9.09% | -$919,600.00 | 0.91 | |
| Avantor, Inc. AVTR | $12.79M | 0.07 | 500,000 | +150% | +$7.67M | 1.27 | |
| The Cooper Companies, Inc. COO | $11.16M | 0.06 | 110,000 | +214.29% | +$7.61M | 1.11 | |
ICON Public Limited Company ICLR | $15.12M | 0.05 | 45,000 | +28.57% | +$3.36M | 1.5 | |
| Humana Inc. HUM | $20.8M | 0.05 | 60,000 | New | +$20.8M | 2.06 | |
| Boston Scientific Corporation BSX | $41.09M | 0.04 | 600,000 | +60% | +$15.41M | 4.07 | |
| Alnylam Pharmaceuticals, Inc. ALNY | $7.47M | 0.04 | 50,000 | +11.11% | +$747,250.00 | 0.74 | |
Cencora COR | $12.15M | 0.03 | 50,000 | -28.57% | -$4.86M | 1.2 | |
| DexCom, Inc. DXCM | $13.87M | 0.03 | 100,000 | -20% | -$3.47M | 1.37 | |
Elevance Health Inc. ELV | $25.93M | 0.02 | 50,000 | +150% | +$15.56M | 2.57 | |
| Regeneron Pharmaceuticals, Inc. REGN | $16.36M | 0.02 | 17,000 | -32% | -$7.7M | 1.62 | |
| Intuitive Surgical, Inc. ISRG | $19.95M | 0.01 | 50,000 | +25% | +$3.99M | 1.98 | |
| Cigna Corporation CI | $14.53M | 0.01 | 40,000 | New | +$14.53M | 1.44 | |
Novartis AG NVS | $21.76M | 0.01 | 225,000 | 0% | +$0 | 2.16 | |
| Merck & Co., Inc. MRK | $31.01M | 0.01 | 235,000 | New | +$31.01M | 3.07 | |
| AbbVie Inc. ABBV | $24.58M | 0.01 | 135,000 | -20.59% | -$6.37M | 2.44 | |
| Eli Lilly and Company LLY | $9.34M | <0.01 | 12,000 | -57.14% | -$12.45M | 0.93 |